focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Redemption

30 Jul 2015 07:02

RNS Number : 5062U
Royal Bank of Scotland Group PLC
30 July 2015
 



THE ROYAL BANK OF SCOTLAND GROUP PLC

Redemption of American Depositary Shares Representing Non-Cumulative USD Preference Shares Series M, N, P and Q

30 July 2015

The Royal Bank of Scotland Group plc ("RBSG") has given notice to holders of the redemption on 1 September 2015 (the "Redemption Date"), in whole, of the following series of Non-cumulative USD Preference Shares and the corresponding series of American Depositary Shares ("ADSs"):

(i) Non-cumulative USD Preference Shares, Series M (ADS CUSIP: 780097796; ADS ISIN: US7800977966), amount outstanding US$578,146,725 (the "Series M preference shares");

(ii) Non-cumulative USD Preference Shares, Series N (ADS CUSIP: 780097770; ADS ISIN: US7800977701), amount outstanding US$552,829,000 (the "Series N preference shares");

(iii) Non-cumulative USD Preference Shares, Series P (ADS CUSIP: 780097762; ADS ISIN: US7800977628), amount outstanding US$247,082,675 (the "Series P preference shares"); and

(iv) Non-cumulative USD Preference Shares, Series Q (ADS CUSIP: 780097754; ADS ISIN: US7800977545), amount outstanding US$516,173,450 (the "Series Q preference shares", and together with the Series M preference shares, the Series N preference shares and the Series P preference shares, the "Preference Shares"),

at the redemption price, with respect to each series of Preference Shares and the corresponding series of ADSs, of US$25.00 per Preference Share and per ADS plus accrued dividends for the current dividend period to the Redemption Date, which dividend shall equal $0.275556 per Series M preference share, $0.273403 per Series N preference share, $0.269097 per Series P preference share and $0.290625 per Series Q preference share. The redemption amount with respect to each series of Preference Shares shall be paid out of distributable profits of RBSG. The Preference Shares will cease to accrue dividends and shall be cancelled and all unmatured dividend coupons and talons (if any) shall become void for any purpose, as from the Redemption Date. 

On the Redemption Date, the depositary for the American depositary receipts evidencing the ADSs will redeem the number of ADSs corresponding to the relevant Preference Shares being redeemed at a price per ADS equal to the per share amount received by the depositary upon redemption of the relevant Preference Shares. As from the Redemption Date, the holders of the ADSs representing each series of Preference Shares will, upon surrender of the ADSs, be entitled to receive funds deposited with The Bank of New York Mellon as depositary with respect to the Preference Shares of that series, without interest. The ADSs will cease to trade on the New York Stock Exchange from the Redemption Date.

Holders of the ADSs should read the notice relating to the redemption of the relevant series of Preference Shares and Letter of Transmittal included in such notice for information on the actions that they need to undertake to receive the redemption proceeds.

For further information and copies of the notices and Letters of Transmittal, please contact:

The Bank of New York Mellon (depositary) at telephone number 1 866 300 4353; international callers may telephone +001 201 680 6825.

 

 

The Royal Bank of Scotland Group plc:

 

RBS Investor Relations

Matthew Richardson

Head of Debt Investor Relations

Tel: +44 (0) 20 7678 1800

 

 

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBSG's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBSG's actual results are discussed in RBSG's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBSG's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBSG does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFLVDLIAFIE
Date   Source Headline
15th Apr 20169:22 amRNSHolding(s) in Company
14th Apr 20165:32 pmRNSAllotment and Issue of New Ordinary Shares
11th Apr 20169:00 amRNSImpact of recent Liability Management Exercise
7th Apr 20162:32 pmRNSBlock listing Interim Review
7th Apr 201612:44 pmRNSPricing and Final Results
7th Apr 201612:43 pmRNSAnnouncement of Final Results
6th Apr 20165:20 pmRNSANNOUNCEMENT OF PRICING INFORMATION
1st Apr 20162:00 pmRNSNotice of AGM
31st Mar 20162:11 pmRNSTotal Voting Rights
31st Mar 20167:00 amRNSRBSG priced $1.5 billion Senior Notes
30th Mar 20161:04 pmRNSCASH TENDER OFFERS FOR EURO AND STERLING NOTES
30th Mar 20161:03 pmRNSCASH TENDER OFFERS ON CERTAIN US DOLLAR SECURITIES
29th Mar 20167:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F WITH THE SEC
22nd Mar 20167:50 amRNSRBS and HMT to retire the DAS
18th Mar 20162:31 pmRNSPublication of Final Terms
15th Mar 20168:45 amRNSMorgan Stanley European Financials Conference
8th Mar 20162:14 pmRNSDirector/PDMR Shareholding
7th Mar 20162:14 pmRNSPublication of Prospectus
29th Feb 20164:51 pmRNSTotal Voting Rights
29th Feb 20162:00 pmRNSDirector/PDMR Shareholding
26th Feb 20167:01 amRNSAnnual Report and Accounts 2015
26th Feb 20167:00 amRNSFinal Results
25th Feb 20165:36 pmRNSHome Member State Confirmations
25th Feb 20164:23 pmRNSDividend Declaration
4th Feb 20163:59 pmRNSRBS February 2016 Restatement
29th Jan 20162:55 pmRNSTotal Voting Rights
27th Jan 20167:00 amRNSTrading Statement
7th Jan 201611:02 amRNSHolding(s) in Company
6th Jan 201611:43 amRNSTotal Voting Rights
31st Dec 201510:50 amRNSTotal Voting Rights
17th Dec 20155:32 pmRNSAllotment and Issue of New Ordinary Shares
17th Dec 20158:59 amRNSAppointment of a Non-Executive Director
16th Dec 20157:27 amRNSUpdate on the disposal of Williams & Glyn - Amend
16th Dec 20157:00 amRNSUpdate on the disposal of Williams & Glyn
7th Dec 20157:20 amRNSDisposal of a portfolio of Irish Real Estate Loans
1st Dec 20157:07 amRNSStatement re 2015 stress test results
30th Nov 20153:15 pmRNSTotal Voting Rights
26th Nov 20155:19 pmRNSImpact of recent Liability Management Exercise
23rd Nov 20153:32 pmRNSPublication of Prospectus
19th Nov 20155:11 pmRNSDividend Declaration
12th Nov 201512:51 pmRNSRBS Investor Seminar: CIB
12th Nov 20159:54 amRNSDirector Declaration
10th Nov 20152:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20151:40 pmRNSVisa Europe Shareholding
30th Oct 20153:35 pmRNSTotal Voting Rights
30th Oct 201512:05 pmRNSDisposal
30th Oct 20157:05 amRNSSale of Remainder of Citizens Financial Group Inc.
30th Oct 20157:00 amRNSInterim Management Statement
15th Oct 20154:00 pmRNSHolding(s) in Company
14th Oct 20158:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.